Dr. Ishita B. Sen

MBBS, DRM, DNB (Nuclear Medicine)

Director & Head – Department of Nuclear Medicine & Molecular Imaging

24+ Years of Experience
Gurgaon

Dr. Ishita B. Sen is an eminent and highly accomplished leader in Nuclear Medicine and Molecular Imaging with more than 24 years of profound clinical experience. She completed her advanced postgraduate qualifications and DNB in Nuclear Medicine from premier national medical centers. Dr. Sen is widely recognized as a pioneer in North India for adopting and standardizing high-end PET-CT imaging and targeted radionuclide therapies for cancer patients. Her clinical focus is on utilizing high-resolution molecular imaging to detect malignancies early and guide oncologists in creating precise, effective treatment strategies.

  • Oncological Molecular Imaging: Precision interpretation of F-18 FDG, Ga-68 PSMA, and Ga-68 DOTATOC PET-CT scans for tumor staging.
  • Radionuclide Therapy (Theranostics): High-dose Lutetium-177 (Lu-177) PSMA therapy for prostate cancer and Lu-177 DOTATATE for neuroendocrine tumors.
  • Thyroid Cancer Theranostics: High-dose Radioiodine (I-131) ablation therapies for differentiated thyroid malignancies.
  • Nuclear Cardiology & Neurology: High-resolution myocardial perfusion imaging and brain SPECT scans for dementia tracking.
  • Played an instrumental role in establishing one of the country’s most advanced, state-of-the-art Nuclear Medicine and Theranostics departments at FMRI Gurgaon.
  • Successfully administered hundreds of targeted Lu-177 radionuclide therapies, providing effective options for patients with advanced, resistant cancers.
  • Held prominent leadership tenures as Head of Nuclear Medicine at major corporate healthcare networks in Delhi-NCR before joining Fortis.
  • Awarded numerous national medals acknowledging clinical excellence and innovation in nuclear medicine imaging.
  • Permanent member of the Society of Nuclear Medicine, India (SNMI) and the European Association of Nuclear Medicine (EANM).